Safety and Efficacy of SAB-185 for Non-hospitalized Adults with COVID-19: A Randomized Clinical Trial

By sjmartinez • July 20, 2024

Chew KW, Taiwo BO, Moser C, Daar ES, Wohl DA, Ritz J, Javan AC, Li JZ, Fischer W, Greninger AL, Bausch C, Luke T, Call R, Neytman G, Giganti MJ, Fletcher CV, Hughes MD, Eron JJ, Currier JS, Smith DM; ACTIV-2/A5401 Study Team. Safety and Efficacy of SAB-185 for Non-hospitalized Adults with COVID-19: A Randomized Clinical Trial. J Infect Dis. 2024 Jul 20:jiae369. doi: 10.1093/infdis/jiae369. Epub ahead of print. PMID: 39028902.

Tags: ACTIV-2, casirivimab/imdevimab, Clinical Trial, covid-19, Harbor UCLA, Infectious Diseases, outpatient treatment, polyclonal antibodies, Publications, SAB-185, transchromosomic

Rapid and reliable diagnosis of mucormycosis using colorimetric loop-mediated isothermal amplification

Gu Y, Ibrahim BA, Gebremariam T, Alkhazraji S, Aerts R, Vanbiervliet Y, Lagrou K, Maertens J, Prattes J, Egger M, Dichtl K, Jenks JD, Hoenigl[...]

Dietary potassium and fiber intake, survival, and health-related quality of life, in a prospective multi-center hemodialysis cohort

Narasaki Y, Li Z, Ong M, Siu MKM, Han SH, Chang TI, Cervantes MK, You AS, Novoa A, Le L, Nguyen DV, Kalantar-Zadeh K, Rhee[...]

Selectivity Modulation of Small Cationic Membrane-Active Cyclic Peptides with Broad-Spectrum Activity against Bacteria and Fungi

Lohan S, Tiwari RK, Maslennikov I, Das Gupta K, Singh S, Parang K. Selectivity Modulation of Small Cationic Membrane-Active Cyclic Peptides with Broad-Spectrum Activity against[...]